1-((BENZYLOXY)CARBONYL)-3-PHENYLAZETIDINE-3-CARBOXYLIC ACID, 95.0%, 100mg

1-((2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95.0%, 100mg

N-Nitrosodiphenylamine>98.0%(HPLC)500g

1-Nitro-2-(prop-2-yn-1-yloxy)benzene, 95+%, 250mg

Methyl 3,6-difluoro-2-hydroxybenzoate, 95+%, 5g

2-Methyl-1-oxo-1,2-dihydroisoquinoline-5-carbonitrile, 97%, 1g

2-(dibutylamino)-1-{2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl}ethan-1-ol, 95.0%, 1g

2-Chloromethyl-6-ethyl-3H-thieno[2,3-d]pyrimidin-4-one, 95.0%, 500mg

(S)-1-METHYL-3-(AMINOMETHYL)PYRROLIDINE, 95.0%, 500mg

Piperidine, PEPTIPURE®, min. 99.5%, for peptide synthesis, 1L, glass packaging

5-Chloro-1H-pyrrolo[2,3-c]pyridine-3-carbonitrile, 97%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(2-((tert-butoxycarbonyl)amino)ethoxy)phenyl)propanoic acid, 97%, 100g

4-(Diphenylhydroxymethyl)benzoic acid, 98.0%, 250mg